Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, South Korea.
Frequently asked questions
What sector does Daewoong (003090) operate in?
Daewoong belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Daewoong (003090) current stock price?
As of the latest data, Daewoong stock price is ₩14,520, with a previous close of ₩14,510. Daewoong gained ₩10 in the last trading session, representing a 0.07% increase.
What is Daewoong (003090) current market capitalization?
Daewoong market cap is approximately 610.38 billion.
What is Daewoong (003090) Earnings Per Share (EPS)?
The trailing EPS is ₩4,268, and the forward EPS is ₩3,899.
What is Daewoong (003090) Price-to-Earnings (P/E) ratio?
Daewoong current P/E ratio is 3.4, with a forward P/E of 3.72.
What is Daewoong (003090) EBITDA?
Daewoong EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 105.96 billion.
Does Daewoong (003090) pay dividends?
Yes. Daewoong pays annual dividends with an annualized yield of 1.38% and an estimated annual payout of ₩200 per share.
When is the next ex-dividend date for Daewoong (003090)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Daewoong (003090) beta (volatility) score?
Daewoong has a beta of 0.275, indicating lower volatility than the overall market.
